Core Ossification of Bone Morphogenetic Protein-2-Loaded Collagenated Bone Mineral in the Sinus
Authors:
- 14 July 2021
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (13-14) , 905-913
Abstract
The objective of this study was to investigate in vitro release kinetics and ossification patterns of bone morphogenetic protein-2-soaked collagenated porcine bone mineral (BMP-2/CPBM) in rabbit sinuses. Release kinetics of BMP-2/CPBM was determined in vitro up to 56 days. In 16 rabbits, BMP-2/CPBM (BMP group) and CPBM alone (control group) were bilaterally grafted in both sinuses. After 4 ( N = 8) and 12 ( N = 8) weeks, radiographic and histologic analyses were performed. Approximately 40% of BMP-2 was released from CPBM during 3 days in vitro ; release maintained at a reduced level until day 56. In vivo , new bone formation in BMP group was dominant at the center and decreased toward the borders of the sinus, while it mainly possessed close to the sinus membrane and basal bone in control group. At the center, significantly more new bone was found in BMP group compared to control group at 4 weeks (29.14% vs. 16.50%; p < 0.05). The total augmented volume of BMP group was significantly greater than control group at 4 (370.13 mm 3 vs. 299.32 mm 3 ) and 12 (400.40 mm 3 vs. 290.10 mm 3 ) weeks ( p < 0.05). In conclusion, BMP-2/CPBM demonstrated a core ossification with a greater augmented volume and new bone formation in the center of the sinus compared to CPBM alone. Impact statement: The center of the augmented maxillary sinus tends to show a slower and inferior new bone formation compared to the sites near the sinus membrane and basal bone. In this study, bone morphogenetic protein-2 (BMP-2) loaded onto collagenated porcine bone mineral (CPBM) resulted in a greater augmented volume and new bone formation at the center of the grafted sinus compared to CPBM alone. Therefore, BMP-2-added CPBM in maxillary sinus augmentation may potentially be beneficial to the clinicians, in terms of accelerating the new bone formation at the center area where the apical half of the implant fixture usually places.Keywords
This publication has 38 references indexed in Scilit:
- Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience databaseThe Spine Journal, 2012
- High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In VivoTissue Engineering Part A, 2011
- Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defectsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2011
- Inflammatory Characteristics of rhBMP-2 In Vitro and in an In Vivo Rodent ModelSpine, 2011
- Retracted: Bone response to hydroxyapatites with open porosity of animal origin (porcine [OsteoBiol®mp3] and bovine [Endobon®]): a radiological and histomorphometric studyClinical Oral Implants Research, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Human Nasal Mucosa Contains Tissue-Resident Immunologically Responsive Mesenchymal Stromal CellsStem Cells and Development, 2009
- Use of Bone Morphogenetic Proteins in Sinus Augmentation ProcedureJournal of Craniofacial Surgery, 2009
- In vitro evaluation of various bioabsorbable and nonresorbable barrier membranes for guided tissue regenerationHead & Face Medicine, 2008
- Histologic and Ultrastructural Analysis of Regenerated Bone in Maxillary Sinus Augmentation Using a Porcine Bone–Derived BiomaterialJournal of Periodontology, 2006